Announcement PDF NEUREN PHARMACEUTICALS LIMITED RESULT OF GENERAL MEETING (ASX REPORT) ANNUAL GENERAL MEETING Tuesday, 28 April, 2015 As required by section 251AA(2) of the Corporations Act 2001 (Commonwealth) the following statistics are provided in respect of each resolution on the agenda. Manner in which the securityholder directed the proxy vote (as at proxy close): Resolution Manner in which votes were cast in person or by proxy on a poll (where applicable) Votes For Votes Against Votes Discretionary Votes Abstain For Against Abstain ** 1 RE-ELECT DR TREVOR SCOTT AS A DIRECTOR 518,292,561 11,285,426 8,154,887 130,000 Passed on a show of hands Passed on a show of hands Passed on a show of hands 2 APPROVE FOR THE PURPOSES OF LISTING RULE 7.1 THE ISSUE OF 20 MILLION LOAN FUNDED SHARES TO DR CLIVE BLOWER 511,933,551 13,330,613 7,837,387 4,761,323 Passed on a show of hands Passed on a show of hands Passed on a show of hands 3 RE-APPOINTMENT OF PRICEWATERHOUSECOOPERS AS THE AUDITOR 529,376,487 72,500 8,184,887 229,000 Passed on a show of hands Passed on a show of hands Passed on a show of hands ** - Note that votes relating to a person who abstains on an item are not counted in determining whether or not the required majority of votes were cast for or against that item Printed: 28/04/2015 11:04:54AM This report was produced from the Link Market Services AGM System v2007 Page 1 of 1